Y-Intercept »

Eyepoint Pharmaceuticals shares owned by Y-Intercept

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $732k 51k 14.30

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
BlackRock
Cormorant Asset Management
Federated Investors
Adage Capital Partners GP
Franklin Resources
Commodore Capital
Jupiter Topco
Vanguard Capital Management
Henderson Group
Paradigm Biocapital Advisors
Citadel Advisors
State Street Corporation
Geode Capital Management
Standard Life Aberdeen

View all funds holding Eyepoint Pharmaceuticals